The meaning of the symbols of mediator seen in a dream.


Cytokines

A family of PROTEIN molecules that carry signals locally between cells. Cytokines are released by cells when activated by antigens (see ANTIGEN), behaving as enhancing mediators for immune response. These proteins include INTERLEUKINS (produced by LEUCOCYTES), lymphokines (produced by lymphocytes – see LYMPHOCYTE), INTERFERON, and tumour necrosis factor, one of whose many functions is killing tumour cells.... cytokines

Acute Respiratory Distress Syndrome (ards)

Formerly known as adult respiratory distress syndrome. A form of acute respiratory failure in which a variety of di?erent disorders give rise to lung injury by what is thought to be a common pathway. The condition has a high mortality rate (about 70 per cent); it is a complex clinical problem in which a disproportionate immunological response plays a major role. (See IMMUNITY.)

The exact trigger is unknown, but it is thought that, whatever the stimulus, chemical mediators produced by cells of the immune system or elsewhere in the body spread and sustain an in?ammatory reaction. Cascade mechanisms with multiple interactions are provoked. CYTOTOXIC substances (which damage or kill cells) such as oxygen-free radicals and PROTEASE damage the alveolar capillary membranes (see ALVEOLUS). Once this happens, protein-rich ?uid leaks into the alveoli and interstitial spaces. SURFACTANT is also lost. This impairs the exchange of oxygen and carbon dioxide in the lungs and gives rise to the clinical and pathological picture of acute respiratory failure.

The typical patient with ARDS has rapidly worsening hypoxaemia (lack of oxygen in the blood), often requiring mechanical ventilation. There are all the signs of respiratory failure (see TACHYPNOEA; TACHYCARDIA; CYANOSIS), although the chest may be clear apart from a few crackles. Radiographs show bilateral, patchy, peripheral shadowing. Blood gases will show a low PaO2 (concentration of oxygen in arterial blood) and usually a high PaCO2 (concentration of carbon dioxide in arterial blood). The lungs are ‘sti?’ – they are less e?ective because of the loss of surfactant and the PULMONARY OEDEMA.

Causes The causes of ARDS may be broadly divided into the following:... acute respiratory distress syndrome (ards)

Curcuma Longa

Linn.

Synonym: C. domestica Valeton.

Family: Zingiberaceae.

Habitat: Cultivated all over India, particularly in West Bengal, Tamil Nadu and Maharashtra.

English: Turmeric.

Ayurvedic: Haridraa, Priyaka, Haridruma, Kshanda, Gauri, Kaanchani, Krimighna, Varavarni- ni, Yoshitapriyaa, Hattavilaasini, Naktaahvaa, Sharvari.

Unani: Zard Chob.

Action: Anti-inflammatory, cholagogue, hepatoprotective, blood-purifier, antioxidant, detoxi- fier and regenerator of liver tissue, antiasthmatic, anti-tumour, anticu- taneous, antiprotozoal, stomachic, carminative. Reduces high plasma cholesterol. Antiplatelet activity offers protection to heart and vessels. Also protects against DNA damage in lymphocytes.

Key application: In dyspeptic conditions. (German Commission E, ESCOP, WHO.) As antiinflammatory, stomachic. (Indian Herbal Pharmacopoeia.)

The rhizomes gave curcuminoids, the mixture known as curcumin, consisting of atleast four phenolic diaryl- heptanoids, including curcumin and monodesmethoxycurcumin; volatile oil (3-5%), containing about 60% of turmerones which are sesquiterpene ketones, and bitter principles, sugars, starch, resin.

Curcumin related phenolics possess antioxidant, anti-inflammatory, gastroprotective and hepatoprotective activities. The antioxidant activity of curcumin is comparable to standard antioxidants—vitamin C and E, BHA and BHT.

The volatile oil, also curcumin, exhibited anti-inflammatory activity in a variety of experimental models (the effects were comparable to those of cortisone and phenylbutazone). Used orally, curcumin prevents the release of inflammatory mediators. It depletes nerve endings of substance P, the neu- rotransmitter of pain receptors.

Curcumin's cholesterol-lowering actions include interfering with intestinal cholesterol uptake, increasing the conversion of cholesterol into bile acids and increasing the excretion of bile acids via its choleretic effects.

Curcuminoids prevent the increases in liver enzymes, SGOT and SGPT; this validates the use of turmeric as a he- patoprotective drug in liver disorders. Curlone, obtained from the dried rhizome, is used against hepatitis.

Turmeric and curcumin increase the mucin content of the stomach and exert gastroprotective effects against stress, alcohol, drug-induced ulcer formation. (Curcumin at doses of 100 mg/kg weight exhibited ulcerogenic activity in rats.)

The ethanolic extract of the rhizome exhibited blood sugar lowering activity in alloxan-induced diabetic rats.

Piperine (a constituent of black and long pepper) enhances absorption and bioavailability of curcumin.

Dosage: Cured rhizome—1-3 g powder. (API Vol. I.)... curcuma longa

Shepry

(American) A mediator who is honest and friendly

Sheprey, Shepri, Sheprie, Shepree, Sheprye, Sheprea... shepry

Anti-inflammatory

1. adj. describing a drug that reduces *inflammation. The various groups of anti-inflammatory drugs act against one or more of the mediators that initiate or maintain inflammation. Some groups suppress only certain aspects of the inflammatory response. The main groups of anti-inflammatory drugs are the *antihistamines, the glucocorticoids (see corticosteroid), and the nonsteroidal anti-inflammatory drugs (see NSAID). 2. n. an anti-inflammatory drug.... anti-inflammatory

Bradykinin

n. a naturally occurring polypeptide consisting of nine amino acids. Bradykinin is a very powerful vasodilator and causes contraction of smooth muscle; it is formed in the blood under certain conditions and is thought to play an important role as a mediator of inflammation. See kinin.... bradykinin

Interleukin

n. any of a family of proteins that control some aspects of haemopoiesis and the immune response (see cytokines). Many interleukins are currently characterized. Interleukin 1 (IL-1) is an inflammatory mediator. Interleukin 2 (IL-2) stimulates T lymphocytes to become *natural killer cells, active against cancer cells, and is being investigated for the treatment of cancer: recombinant interleukin 2 (aldesleukin, Proleukin), administered by subcutaneous injection, can be of benefit in the treatment of renal cell carcinoma.... interleukin

Asthma

Asthma is a common disorder of breathing characterised by widespread narrowing of smaller airways within the lung. In the UK the prevalence among children in the 5–12 age group is around 10 per cent, with up to twice the number of boys affected as girls. Among adults, however, the sex incidence becomes about equal. The main symptom is shortness of breath. A major feature of asthma is the reversibility of the airway-narrowing and, consequently, of the breathlessness. This variability in the obstruction may occur spontaneously or in response to treatment.

Cause Asthma runs in families, so that parents with asthma have a strong risk of having children with asthma, or with other atopic (see ATOPY) illnesses such as HAY FEVER or eczema (see DERMATITIS). There is therefore a great deal of interest in the genetic basis of the condition. Several GENES seem to be associated with the condition of atopy, in which subjects have a predisposition to form ANTIBODIES of the IgE class against allergens (see ALLERGEN) they encounter – especially inhaled allergens.

The allergic response in the lining of the airway leads to an in?ammatory reaction. Many cells are involved in this in?ammatory process, including lymphocytes, eosinophils, neutrophils and mast cells. The cells are attracted and controlled by a complex system of in?ammatory mediators. The in?amed airway-wall produced in this process is then sensitive to further allergic stimuli or to non-speci?c challenges such as dust, smoke or drying from the increased respiration during exercise. Recognition of this in?ammation has concentrated attention on anti-in?ammatory aspects of treatment.

Continued in?ammation with poor control of asthma can result in permanent damage to the airway-wall such that reversibility is reduced and airway-narrowing becomes permanent. Appropriate anti-in?ammatory therapy may help to prevent this damage.

Many allergens can be important triggers of asthma. House-dust mite, grass pollen and animal dander are the commonest problems. Occupational factors such as grain dusts, hard-metals fumes and chemicals in the plastic and paint industry are important in some adults. Viral infections are another common trigger, especially in young children.

The prevalence of asthma appears to be on the increase in most countries. Several factors have been linked to this increase; most important may be the vulnerability of the immature immune system (see IMMUNITY) in infants. High exposure to allergens such as house-dust mite early in life may prime the immune system, while reduced exposure to common viral infections may delay the maturation of the immune system. In addition, maternal smoking in pregnancy and infancy increases the risk.

Clinical course The major symptoms of asthma are breathlessness and cough. Occasionally cough may be the only symptom, especially in children, where night-time cough may be mistaken for recurrent infection and treated inappropriately with antibiotics.

The onset of asthma is usually in childhood, but it may begin at any age. In childhood, boys are affected more often than girls but by adulthood the sex incidence is equal. Children who have mild asthma are more likely to grow out of the condition as they go through their teenaged years, although symptoms may recur later.

The degree of airway-narrowing, and its change with time and treatment, can be monitored by measuring the peak expiratory ?ow with a simple monitor at home – a peak-?ow meter. The typical pattern shows the peak ?ow to be lowest in the early morning and this ‘morning dipping’ is often associated with disturbance of sleep.

Acute exacerbations of asthma may be provoked by infections or allergic stimuli. If they do not respond quickly and fully to medication, expert help should be sought urgently since oxygen and higher doses of drugs will be necessary to control the attack. In a severe attack the breathing rate and the pulse rate rise and the chest sounds wheezy. The peak-?ow rate of air into the lungs falls. Patients may be unable to talk in full sentences without catching their breath, and the reduced oxygen in the blood in very severe attacks may produce the blue colour of CYANOSIS in the lips and tongue. Such acute attacks can be very frightening for the patient and family.

Some cases of chronic asthma are included in the internationally agreed description CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) – a chronic, slowly progressive disorder characterised by obstruction of the air?ow persisting over several months.

Treatment The ?rst important consideration in the treatment of asthma is avoidance of precipitating factors. When this is a speci?c animal or occupational exposure, this may be possible; it is however more di?cult for house-dust mite or pollens. Exercise-induced asthma should be treated adequately rather than avoiding exercise.

Desensitisation injections using small quantities of speci?c allergens are used widely in some countries, but rarely in the UK as they are considered to have limited value since most asthma is precipitated by many stimuli and controlled adequately with simple treatment.

There are two groups of main drugs for the treatment of asthma. The ?rst are the bronchodilators which relax the smooth muscle in the wall of the airways, increase their diameter and relieve breathlessness. The most useful agents are the beta adrenergic agonists (see ADRENERGIC RECEPTORS) such as salbutamol and terbutaline. They are best given by inhalation into the airways since this reduces the general side-effects from oral use. These drugs are usually given to reverse airway-narrowing or to prevent its onset on exercise. However, longer-acting inhaled beta agonists such as salmeterol and formoterol or the theophyllines given in tablet form can be used regularly as prevention. The beta agonists can cause TREMOR and PALPITATION in some patients.

The second group of drugs are the antiin?ammatory agents that act to reduce in?ammation of the airway. The main agents in this group are the CORTICOSTEROIDS. They must be taken regularly, even when symptoms are absent. Given by inhalation they have few side-effects. In acute attacks, short courses of oral steroids are used; in very severe disease regular oral steroids may be needed. Other drugs have a role in suppressing in?ammation: sodium cromoglycate has been available for some years and is generally less e?ective than inhaled steroids. Newer agents directed at speci?c steps in the in?ammatory pathway, such as leukotriene receptor-antagonists, are alternative agents.

Treatment guidelines have been produced by various national and international bodies, such as the British Thoracic Society. Most have set out treatment in steps according to severity, with objectives for asthma control based on symptoms and peak ?ow. Patients should have a management plan that sets out their regular treatment and their appropriate response to changes in their condition.

Advice and support for research into asthma is provided by the National Asthma Campaign.

See www.brit-thoracic.org.uk

Prognosis Asthma is diagnosed in 15–20 per cent of all pre-school children in the developed world. Yet by the age of 15 it is estimated that fewer than 5 per cent still have symptoms. A study in 2003 reported on a follow-up of persons born in 1972–3 who developed asthma and still had problems at the age of nine. By the time these persons were aged 26, 27 per cent were still having problems; around half of that number had never been free from the illness and the other half had apparently lost it for a few years but it had returned.... asthma

Non-steroidal Anti-inflammatory Drugs (nsaids)

These act by inhibiting the formation of PROSTAGLANDINS which are mediators of INFLAMMATION. They act both as ANALGESICS to relieve pain, and as inhibitors of in?ammation. Aspirin is a classic example of such a compound. Newer compounds have been synthesised with the aim of producing fewer and less severe side-effects. They are sometimes preferred to aspirin for the treatment of conditions such as RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, sprains, strains and sports injuries. Their main side-effects are gastrointestinal: gastric ulcers and gastric haemorrhage may result (see STOMACH, DISEASES OF). This is because prostaglandins are necessary for the production of the mucous protective coat in the stomach and, when the production of prostaglandin is inhibited, the protection of the stomach is compromised. NSAIDs should therefore be used with caution in patients with DYSPEPSIA and gastric ulceration. The various nonsteroidal anti-in?ammatory drugs di?er little from each other in e?cacy, although there is considerable variation in patient response. Ibuprofen is one of the ?rst choices in this group of drugs as it combines good e?cacy with a low incidence of side-effects and administration is only required twice daily. Other drugs in this series include diclofenac, fenbufen, fenclofenac, fenoprofen, feprazone, ?urbiprofen, indomethacin, indoprofen, ketoprofen, ketorolac, naproxen, piroxicam, sulindac, tiaprofenic acid and tolmetin.... non-steroidal anti-inflammatory drugs (nsaids)

Sodium Cromoglycate

Used in the prophylaxis of ASTHMA, it is administered by inhalation and can reduce the incidence of asthmatic attacks but is of no value in the treatment of an acute attack. It acts by preventing the release of pharmacological mediators of BRONCHOSPASM, particularly HISTAMINE, by stabilising mast-cell membranes. It is of particular use in patients whose asthma has an allergic basis; children over four may respond better than adults. It is less potent than inhaled steroids. The dose frequency is adjusted to the patient’s response but is usually administered by inhalation four times daily. Sodium cromoglycate is also used in the prophylaxis of allergic RHINITIS and to treat allergic conjunctivitis (see under EYE, DISORDERS OF).... sodium cromoglycate

Histamine

n. a compound derived from the amino acid histidine. It is found in nearly all tissues of the body, associated mainly with the *mast cells. Histamine has pronounced pharmacological activity, causing dilation of blood vessels and contraction of smooth muscle (for example, in the lungs). It is an important mediator of inflammation and is released in large amounts after skin damage (such as that due to animal venoms and toxins), producing a characteristic skin reaction (consisting of flushing, a flare, and a weal). Histamine is also released in anaphylactic reactions and allergic conditions, including asthma, and gives rise to some of the symptoms of these conditions. See also anaphylaxis; antihistamine.... histamine

Nitric Oxide

an important member of the group of gaseous mediators, which – together with amine mediators (e.g. adrenaline, noradrenaline, histamine, acetylcholine) and lipid mediators (e.g. prostaglandins) – produce many physiological responses (e.g. smooth muscle relaxation). Nitric oxide is involved in the manifestations of sepsis and septic shock. Formula: NO.... nitric oxide

Nsaid

(nonsteroidal anti-inflammatory drug) any one of a large group of drugs used for pain relief, particularly in rheumatic disease associated with inflammation but also in dysmenorrhoea and metastatic bone disease. NSAIDs act by inhibiting the cyclo-oxygenase enzymes (COX-1 and COX-2) responsible for controlling the formation of *prostaglandins, which are important mediators of inflammation. They include *aspirin, *ibuprofen, *ketoprofen, and *naproxen. Adverse effects include gastrointestinal bleeding and ulceration. Some NSAIDs act by selectively inhibiting COX-2 and are therefore less likely to cause gastric side-effects (see COX-2 inhibitor).... nsaid

Pirfenidone

n. a drug with antifibrotic and anti-inflammatory properties that is used to treat *idiopathic pulmonary fibrosis. It is thought to reduce fibroblast proliferation, inhibit *transforming growth factor-?-stimulated collagen production, and reduce the production of fibrogenic mediators. Pirfenidone has also been shown to reduce production of inflammatory mediators, such as *tumour necrosis factor and interleukin 1 (IL-1). Side effects include gastrointestinal upsets.... pirfenidone

Prostaglandin

n. one of a group of hormone-like substances present in a wide variety of tissues and body fluids (including the uterus, brain, lungs, kidney, and semen). Prostaglandins have many actions; for example, they cause contraction of smooth muscle (including that of the uterus), dilation of blood vessels, and are mediators in the process of inflammation (aspirin and other *NSAIDs act by blocking their production). They are also involved in the production of mucus in the stomach, which provides protection against acid gastric juice; use of NSAIDs reduces this effect and predisposes to peptic ulceration, the principal side-effect of these drugs. There are nine classes of prostaglandins (PGA–I), within which individual prostaglandins are denoted by numerals (e.g. PGE1). Synthetic prostaglandins are used to induce labour or produce abortion (see dinoprostone; gemeprost) and to treat peptic ulcers (see misoprostol), congenital heart disease in newborn babies (see alprostadil), and glaucoma (see latanoprost).... prostaglandin



Recent Searches